Sorrento Therapeutics Inc (NASDAQ:SRNE)

13.79
Delayed Data
As of May 29
 -0.01 / -0.07%
Today’s Change
3.10
Today|||52-Week Range
15.00
+36.94%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +45.03% increase from the last price of 13.79.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$1.2M
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.04%
 
 
 
 
 
 
Growthannually 12.33%
 
 
 

Sales

Growthquarterly 44.40%
 
 
 
 
 
 
Growthannually 821.52%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account